BioSpace News Archive

Jaime will lead all activities related to information technology, data management and security, data analytics, and mobile/connected health solutions.

Hundreds of hearing health organizations have unified in support of a common cause, launching The Campaign for Better Hearing in the United States.

Bio-Techne Corporation (NASDAQ:TECH) today announced that Chuck Kummeth, President and Chief Executive Officer will present at the 8th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 27th, 2019, at 10:30 a.m. EST.

Introduction of Open Abdomen Management System for Critical Care Patients Brings Clinically Demonstrated Technology to Japanese Market

Indivior PLC announced that its U.S. affiliate, Indivior Inc., has launched an authorized generic version of SUBOXONE® Sublingual Film in the U.S. The authorized generic is being marketed and distributed on Indivior’s behalf by Sandoz Inc.

The International Space Station Research and Development Conference announced that Dr. Sanjay Gupta, chief medical correspondent for CNN, will be a keynote speaker at its 8th annual meeting held at the Hyatt Regency in Atlanta, Georgia, July 29 to August 1, 2019.

Oxford Immunotec Global PLC (Nasdaq:OXFD) (the “Company”), a global, high-growth diagnostics company, today announced that it plans to release fourth quarter and full year 2018 financial results after the close of the market on Monday, March 11, 2019.

Point-of-Care Device Seamlessly Fits Into Clinic Workflow, Increasing Access to Important Test

PatientPing, the nation’s most comprehensive care coordination platform, announced that it has teamed up with Humana Inc. , one of the nation’s leading health and well-being companies, on a new care coordination focus for Humana Medicare Advantage members in North Carolina.

Syncona Ltd, a leading healthcare company focused on founding, building and funding global leaders in life science, announces that its portfolio company, Gyroscope Therapeutics (Gyroscope), an ophthalmology company developing genetically defined therapies for retinal diseases such as age-related macular degeneration (AMD), has commenced dosing in a Phase I/II trial in dry AMD